New Progress of Research | the Clinical Trial Project of the World's First Stem Cell Innovative Drug for Ulcerative Colitis Start in the Affiliated Hospital of Qingdao UniversityRecently, the clinical test project of Human Umbilical Cord Mesenchymal Stem Cell Injection studied by the scientific research team of Qingdao Allcare Biomedical Development(ABMO) for patients with moderate and severe ulcerative colitis initiated a clinical trial in the Affiliated Hospital of Qingdao University, and subjects are recruited to the whole regions.
Leadingpharm Strategic Cooperated with China Certification & Inspection （Group）., Ltd, Looking for In-depth Co-Development in Medical Analysis and TestingOn December 7, 2021, Leadingpharm and China Certification & Inspection （Group）Co . , Ltd .（CCIC） signed a strategic cooperation agreement. The two sides will give full play to their respective resources and technical advantages, conduct in-depth cooperation in the field of pharmaceutical analysis and testing, and jointly build a public service platform for testing and evaluation of health product.
Leadingpharm and Huluwa Work Together to Jointly Build a High-end Pediatric Drug R&D PlatformRecently, Leadingpharm and Huluwa Pharmaceutical Group signed a memorandum of strategic cooperation, and the two sides reached a cooperation intention on the construction of a high-end pediatric drug research institute.
Leadingpharm has Strategic Cooperated with Hillgene, Showing the New Mode of CXO Service!On October 26, the Leadingpharm-Hillgene Strategic Cooperation Signing Ceremony was successfully held in “the Future Medical and Health Leaders Forum and the Bio Innovators Academy Annual Meeting”.
Congratulation! | Congratulate Mr. Tao Xinhua, Chairman of Leadingpharm, on Awarding the Title of "Top 10 Rising Star of China’s Pharmaceutical Industry in 2020"Mr. Tao Xinhua, chairman of Leadingpharm, won the honorary title of "Top 10 Rising Star of China’s Pharmaceutical Industry in 2020 - Leader of CXO-Whole-Industry-Chain Service System " in the "Most Influential Company Press Conference of China's Pharmaceutical Industry in 2020" .